{"podcast":{"title":"Decera Clinical Education Oncology Podcast","slug":"decera-clinical-education-oncology-podcast-1302999","podcast_index_feed_id":1302999,"rss_url":"https://feeds.simplecast.com/GlfUTtJq","website_url":"https://oncologypodcast.simplecast.com","image_url":"https://image.simplecastcdn.com/images/ec61b327-3a4f-4bed-a4d2-7c7d2df62891/2d9bf1a9-d5c4-4079-9b3e-a531bfcf7774/3000x3000/decera-onc-podcast-show-icon.jpg?aid=rss_feed","author":"Decera Clinical Education","episode_count":253,"summary":"Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.","last_synced_at":"2026-07-15T02:18:52.844818+00:00","page_url":"https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999"},"episode":{"title":"Experts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metastatic Breast Cancer","slug":"experts-discuss-novel-approaches-to-first-line-therapy-for-her2-positive-metastatic-breast-cancer","published_at":"2026-04-17T18:05:54+00:00","page_url":"https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/experts-discuss-novel-approaches-to-first-line-therapy-for-her2-positive-metastatic-breast-cancer","show_page_url":"https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999","url":"https://oncologypodcast.simplecast.com/episodes/experts-discuss-novel-approaches-to-first-line-therapy-for-her2-positive-metastatic-breast-cancer-nzA_gF1n","audio_url":"https://afp-928689-injected.calisto.simplecastaudio.com/1d8e143b-904e-45be-b6c5-8fba793d9d74/episodes/76b601e6-e123-48d8-939d-9a49e0851115/audio/128/default.mp3?aid=rss_feed&awCollectionId=1d8e143b-904e-45be-b6c5-8fba793d9d74&awEpisodeId=76b601e6-e123-48d8-939d-9a49e0851115&feed=GlfUTtJq","summary":"Listen to Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, as they discuss recent developments in the field of first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer.","meta_description":"Listen to Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, as they discuss recent developments in the field of first-line therapy and maintenance treatme…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1361,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/experts-discuss-novel-approaches-to-first-line-therapy-for-her2-positive-metastatic-breast-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/experts-discuss-novel-approaches-to-first-line-therapy-for-her2-positive-metastatic-breast-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}